- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rivaroxaban (Xarelto, BAY59-7939)
Total 245 results
-
BayerJanssen Research & Development, LLCCompletedVenous ThromboembolismSwitzerland, China, Slovakia, France, Germany, Hungary, Korea, Republic of, Singapore, South Africa, Spain, Sweden, Philippines, Australia, Austria, Colombia, Czech Republic, Estonia, Hong Kong, Italy, Latvia, Lebanon, Lithuania, Macedonia... and more
-
BayerJanssen Research & Development, LLCCompletedVenous Thrombosis | Deep Vein ThrombosisSwitzerland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Moldova, Republic of, Slovenia, Ukraine, United Kingdom, Israel, Portugal, Belgium, Denmark, Greece, Netherlands, Canada, Norway
-
BayerCompletedVenous ThromboembolismItaly, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, Norway, United Kingdom, France
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationUnited States
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCNot yet recruitingVenous Thromboembolism | Children Under 2 YearsSpain, Sweden, Denmark, France
-
BayerJanssen Research & Development, LLCCompletedDeep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)Turkey, Russian Federation, Korea, Republic of, Mexico, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Egypt, Kazakhstan, Algeria, Lebanon, Saudi Arabia, Ukraine, Jordan, Kenya, Kuwait, Morocco, Qatar, United Arab Emirates
-
BayerJanssen Research & Development, LLC; Colorado Prevention CenterCompletedPeripheral Artery DiseasePoland, Belgium, France, Spain, China, Korea, Republic of, United States, Switzerland, Estonia, Portugal, Japan, Hungary, Canada, Netherlands, Finland, Austria, United Kingdom, Germany, Czechia, Thailand, Brazil, Denmark, Italy, Russian... and more
-
BayerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedVenous ThromboembolismBelgium, France, Norway, Spain, China, Taiwan, United States, Switzerland, Colombia, Canada, Estonia, New Zealand, Finland, Italy, Portugal, Japan, Singapore, Germany, Greece, Australia, Sweden, Austria, Chile, Slovakia, United Kingdom, M... and more
-
BayerCompletedVenous ThromboembolismPoland, United States, India, Denmark, Canada, Sweden, Bulgaria, Israel, Lithuania, Norway, Pakistan, Mexico, Sri Lanka
-
BayerJanssen Research & Development, LLCCompleted
-
BayerCompleted
-
BayerCompletedEmbolism, Atrial Fibrillation and Venous ThrombosisJapan
-
BayerJanssen Scientific Affairs, LLCCompletedVenous Thrombosis | Atrial Fibrillation | Acute Coronary Syndrome | Pulmonary EmbolismNetherlands
-
BayerJanssen Research & Development, LLCTerminatedNon-valvular Atrial FibrillationNorway
-
BayerCompleted
-
BayerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedVenous ThrombosisUnited Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, United States, New Zealand, Poland, India, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Brazil, Denmark, Germany, Norw... and more
-
BayerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedPulmonary EmbolismUnited Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Switzerland, United States, New Zealand, Poland, India, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Estonia, Thailand, Brazil, Germany, Korea, Republic... and more
-
BayerJanssen Research & Development, LLCCompletedVenous Thrombosis | Atrial Fibrillation | Acute Coronary Syndrome | Pulmonary EmbolismGermany
-
BayerCompleted
-
BayerJanssen Scientific Affairs, LLCCompletedVenous Thrombosis | Atrial Fibrillation | Acute Coronary Syndrome | Pulmonary EmbolismSweden
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationUnited States
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationBelgium, France, Spain, China, Italy, United States, Canada, South Africa, Portugal, Singapore, Germany, Greece, Netherlands, United Kingdom, Brazil, Denmark, Finland
-
BayerJanssen, LPCompletedAtrial Fibrillation (Prevention of Stroke)Germany
-
BayerJanssen Scientific Affairs, LLCCompletedAtrial FibrillationFrance
-
BayerJanssen Research & Development, LLCCompletedNonvalvular Atrial FibrillationUnited States
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationSpain
-
BayerJanssen Research & Development, LLCCompletedNon-valvular Atrial Fibrillation (NVAF)Korea, Republic of
-
BayerJanssen Research & Development, LLCActive, not recruiting
-
BayerJanssen Research & Development, LLCCompletedVenous Thrombosis and Pulmonary EmbolismItaly, Germany, United Kingdom, France, Belgium, Canada, Netherlands, Spain, Denmark, Australia
-
BayerJanssen Scientific Affairs, LLCCompleted
-
BayerCompletedTreatment of Venous Thromboembolism in Cancer Patients | Prophylaxis of Recurrent Venous Thromboembolism in Cancer PatientsUnited States
-
BayerJanssen Research & Development, LLCCompletedPulmonary EmbolismJapan
-
BayerJanssen Research & Development, LLCCompletedVenous Thrombosis | Atrial Fibrillation | Acute Coronary Syndrome | Pulmonary EmbolismUnited Kingdom
-
BayerJanssen Research & Development, LLCCompletedPulmonary EmbolismChina
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationTaiwan
-
BayerCompletedVenous Thromboembolism | PreventionDenmark, Italy, China, Indonesia, Colombia, Portugal, United States, Australia, Korea, Republic of, Taiwan, Canada, Estonia, New Zealand, Brazil, Mexico, South Africa, Peru, United Kingdom, Latvia, India, Lithuania, Sweden, Norway
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Scientific Affairs, LLCCompleted
-
BayerCompletedVenous ThromboembolismItaly, Spain, Poland, United States, Czech Republic, Canada, Denmark, Netherlands, Belgium, Chile, Slovakia, Hungary, Austria, France, Germany, South Africa, Sweden, Turkey, Colombia, Israel, Mexico, Argentina, Norway, Brazil, Lithuania, ... and more
-
BayerCompletedVenous Thrombosis | Deep Vein ThrombosisBelgium, Israel, Italy, Spain, Switzerland, Colombia, New Zealand, Hungary, Canada, Sweden, Austria, Czechia, Germany, Poland, Netherlands, Peru, South Africa, Australia, Brazil
-
BayerJanssen Scientific Affairs, LLCCompletedDeep Vein ThrombosisJapan
-
BayerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedVenous ThromboembolismFrance, Italy, Czech Republic, Canada, Netherlands, Australia, United States, Poland, South Africa, Sweden, Israel, Denmark, Brazil
-
BayerCompletedCoronary Artery Disease | Peripheral Artery DiseaseSpain, Belgium, Italy, Korea, Republic of, Russian Federation, Taiwan, China, Colombia, Switzerland, Slovenia
-
BayerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
BayerCompletedThromboembolism | PreventionBelgium, Denmark, Austria, Germany, Netherlands, Poland, Sweden, Israel, France, Norway, United Kingdom
-
BayerCompletedVenous Thromboembolism | PreventionBelgium, Italy, Poland, Spain, China, France, Denmark, Netherlands, Austria, Germany, Mexico, South Africa, Sweden, Colombia, Israel, Canada, Norway, Peru, Czech Republic